Barclays »

Predictive Oncology shares owned by Barclays

Quarter-by-quarter ownership of Predictive Oncology (AGPU) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Predictive Oncology

Tip: Access up to 7 years of quarterly data

All positions including Predictive Oncology held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Predictive Oncology by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.2k 557 7.58

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Predictive Oncology

Jane Street
Diametric Capital
Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
XTX Topco
BlackRock
Citadel Advisors
Alpine Partners VI
Persistent Asset Partners
UBS Group
Wells Fargo & Company
Tower Research Capital
Bnp Paribas Arbitrage, Snc
Carnegie Mellon University

View all funds holding Predictive Oncology